Post-SARS-CoV-2 infection and post-vaccine-related neurological complications share clinical features and the same positivity to anti-ACE2 antibodies.

MLA

Bellucci, Margherita, et al. “Post-SARS-CoV-2 Infection and Post-Vaccine-Related Neurological Complications Share Clinical Features and the Same Positivity to Anti-ACE2 Antibodies.” Frontiers in Immunology, Aug. 2024, pp. 01–08. EBSCOhost, https://doi.org/10.3389/fimmu.2024.1398028.

APA

Bellucci, M., Bozzano, F. M., Castellano, C., Pesce, G., Beronio, A., Farshchi, A. H., Limongelli, A., Uccelli, A., Benedetti, L., & De Maria, A. (2024). Post-SARS-CoV-2 infection and post-vaccine-related neurological complications share clinical features and the same positivity to anti-ACE2 antibodies. Frontiers in Immunology, 01–08. https://doi.org/10.3389/fimmu.2024.1398028

Chicago

Bellucci, Margherita, Federica Maria Bozzano, Chiara Castellano, Giampaola Pesce, Alessandro Beronio, Alireza Hajabbas Farshchi, Alessandro Limongelli, Antonio Uccelli, Luana Benedetti, and Andrea De Maria. 2024. “Post-SARS-CoV-2 Infection and Post-Vaccine-Related Neurological Complications Share Clinical Features and the Same Positivity to Anti-ACE2 Antibodies.” Frontiers in Immunology, August, 01–08. doi:10.3389/fimmu.2024.1398028.